Clinical Trial Update: A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu... [NA]

View source ↗

Summary

This ClinicalTrials.gov entry describes a recruiting study evaluating next-generation sequencing for monitoring B-cell recovery to guide management after CAR-T–…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: B-All, Acute Lymphoblastic Leukemia | NA | Status: RECRUITING